Alla Berezovskaya - Concepedia

Author

Alla Berezovskaya

Dana-Farber Cancer Institute

Also Known As

A Berezovskaya, Alla Berezovskaya, Alla Berezovskaya Berezovskaya

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Boston Children's Hospital University of Toronto

About

Alla Berezovskaya is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.8K
2	Cell Biology	10	10	986
3	Engineering	1	1	797
4	Health Sciences	1	1	45
5	Natural Sciences	1	1	74

Alla Berezovskaya

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element Marc R. Mansour, Brian J. Abraham, Lars Anders, Science EngineeringMixed-phenotype Acute LeukemiaGeneticsMolecular BiologyEpigenetics	2014	797
Maintenance of Human T Cell Anergy: Blocking of IL-2 Gene Transcription by Activated Rap1 Vassiliki A. Boussiotis, Gordon J. Freeman, Alla Berezovskaya, Science	1997	411
IL-10–producing T cells suppress immune responses in anergic tuberculosis patients Vassiliki A. Boussiotis, Eunice Y. Tsai, Edmond J. Yunis, Journal of Clinical Investigation	2000	400
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells Dimitrios Tzachanis, Gordon J. Freeman, Naoto Hirano, Nature Immunology Signal TransductionNegative RegulatorT-regulatory CellImmunologyCellular Regulatory Mechanism	2001	274
p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes Vassiliki A. Boussiotis, Gordon J. Freeman, Patricia A. Taylor, Nature Medicine InflammationCytokineAnergy FactorAutoimmune DiseaseImmune Cell Development	2000	233
CD28 Costimulation Mediates T Cell Expansion Via IL-2-Independent and IL-2-Dependent Regulation of Cell Cycle Progression Leonard J. Appleman, Alla Berezovskaya, Isabelle Grass, The Journal of Immunology	2000	200
Long-Lived Antitumor CD8+ Lymphocytes for Adoptive Therapy Generated Using an Artificial Antigen-Presenting Cell Marcus O. Butler, Jeng-Shin Lee, Sascha Ansén, Clinical Cancer Research	2007	134
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells Julia Etchin, Alla Berezovskaya, Amy Saur Conway, Leukemia	2016	121
Establishment of Antitumor Memory in Humans Using in Vitro–Educated CD8 <sup>+</sup> T Cells Marcus O. Butler, Philip Friedlander, Matthew I. Milstein, Science Translational Medicine Antitumor MemoryImmune RegulationImmunologyImmunoeditingAdvanced-stage Melanoma Patients	2011	103
A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance Lequn Li, Yoshiko Iwamoto, Alla Berezovskaya, Nature Immunology T Cell ToleranceSignal TransductionCell RegulationCheckpoint Inhibitor Smad3Receptor Tyrosine Kinase	2006	89

Page 1